Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
12.53
+0.27 (2.16%)
At close: Oct 29, 2025, 4:00 PM EDT
12.74
+0.21 (1.72%)
After-hours: Oct 29, 2025, 5:28 PM EDT
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $134.85 million as of October 29, 2025. Its market cap has increased by 250.54% in one year.
Market Cap
134.85M
Enterprise Value
76.85M
1-Year Change
250.54%
Ranking
Category
Stock Price
$12.53
Market Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $134.85M, a decrease of -94.62%. That is a compound annual growth rate of -41.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 132.00M | 90.62% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | 2.40B | -4.35% |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |